Press Releases from Dyskinesia Therapeutics-Pharma Proff (1 total)
Dyskinesia Therapeutics- Pipeline Analysis 2018 | SOM Biotech, Neurocrine Biosci …
Dyskinesia is a type of movement disorder, characterized by irregular and involuntary muscle movements, and diminished voluntary movements. This disease can occur in patients taking…
Go To Page:
